ロード中...
The ADMIT series — Issues in Inhalation Therapy. 3) Mild persistent asthma: the case for inhaled corticosteroid therapy
Mild persistent asthma should be treated with continuous infixed corticosteroids (ICS), which reduces exacerbations of disease, controls symptoms and reduces bronchial mucosal inflammation. Most patients can be controlled with low dosage ICS (≤ 500 mcg/day beclometasone or equivalent) and there is l...
保存先:
| 出版年: | Prim Care Respir J |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6619267/ https://ncbi.nlm.nih.gov/pubmed/19513496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4104/pcrj.2009.00035 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|